Subcutaneous Panniculitis-Like T-Cell Lymphoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Subcutaneous Panniculitis-Like T-Cell Lymphoma

hematologic malignancy

Identifier: CI-CAN-00006845
Entity page: /cancer/subcutaneous-panniculitis-like-t-cell-lymphoma ↗
Edges: 23

Neighbours: 13 drugs10 trials
Drawn: 23 of 23 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Subcutaneous Panniculitis-Like T-Cell Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived13 of 13
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Subcutaneous Panniculitis-Like T-Cell Lymphoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · condition mapped CURATED_BROADER · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05475925Phase 1/Phase 2 · recruiting A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03598998Phase 1/Phase 2 · active not recruiting Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04795869Phase 2 · withdrawn Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma · condition mapped CURATED_BROADER · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01445535Phase 1 · completed Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02533700Phase 2 · unknown CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01746992Phase 4 · unknown CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (5 active)	—	—	Subcutaneous Panniculitis-Like T-Cell Lymphoma	1	Observed	clinicaltrials	graph →